All posts from in,

Wynnefield Target And Strategic Alternatives

The Wynnefield Capital target, Omega Protein (NYSE: OME), isn't catching a the big break Wynnefield was looking for since the announcement that it's exploring strategic alternatives.

Wynnefield got involved back in August and shares are up only 5% since then. Last week, the company announced it was in the process of a review of strategic alternatives to enhance...